Concepedia

James D. Lord

JD

30

Publications

2.4K

Citations

24

H-Index

1994

Active since

Affiliations

Virginia Mason Medical Center(Current)

Benaroya Research Institute

University of Washington

Fred Hutch Cancer Center

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa

James D. Lord is an author at Virginia Mason Medical Center specializing in medicine, immunology, and inflammation.

Top concepts

MedicineImmunologyInflammationPathologyAutoimmunityCell BiologyAutoimmune DiseaseImmunotherapyCell SignalingGastroenterology

Publications per year

1994–2024

30

Publications

30

Cytoplasmic domains of the interleukin-2 receptor β and γ chains mediate the signal for T-cell proliferation

Brad H. Nelson, James D. Lord, Philip D. Greenberg · Nature · 1994 · 340 citations

Cytokine, Signal Transduction, γ Chains +10

New Role for Shc in Activation of the Phosphatidylinositol 3-Kinase/Akt Pathway

Haihua Gu, Hiroyuki Maeda, James J. Moon et al. · Molecular and Cellular Biology · 2000 · 262 citations · Full text

The IL-2 Receptor Promotes Lymphocyte Proliferation and Induction of the c- <i>myc, bcl-2,</i> and <i>bcl-x</i> Genes Through the <i>trans-</i> Activation Domain of Stat5

James D. Lord, Bryan C. McIntosh, Philip D. Greenberg et al. · The Journal of Immunology · 2000 · 229 citations

Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial

Brian G. Feagan, Bruce E. Sands, William J. Sandborn et al. · The Lancet. Gastroenterology & hepatology · 2023 · 208 citations

Systemic Treatment, Golimumab Monotherapy, Gastroenterology +4

Cutting Edge: High Molecular Weight Hyaluronan Promotes the Suppressive Effects of CD4+CD25+ Regulatory T Cells

Paul L. Bollyky, James D. Lord, Susan Masewicz et al. · The Journal of Immunology · 2007 · 172 citations

Rows per page

1–5 of 30